India struggles with a quit success rate under 5%: Experts back OTC access to NRT across all formats and dosages, including 2 mg and 4 mg
With 267 million tobacco users, improving access to evidence-based cessation tools is…
Cabaletta Bio Announces Multiple Upcoming Presentations, Including Data on Rese-cel without Preconditioning and Rese-cel with Automated Manufacturing, at the ASGCT 2026 Annual Meeting
April 27, 2026 17:00 ET | Source: Cabaletta Bio PHILADELPHIA, April 27,…
Mantle Confirms Full Network Security and Coordinates Recovery With Aave, Including Potential Treasury Participation Following rsETH by KelpDAO Incident
DUBAI, UAE, April 21, 2026 /PRNewswire/ -- Mantle, the premier distribution layer…
Total Investment of Approx. USD 8.5 Million in Malaria and NTD R&D Projects With Partners Including MMV, GSK, Tanabe Pharma, Eisai and DNDi
TOKYO, April 22, 2026 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund…
Other World Computing (OWC) Launches MacDrive 12 at NAB 2026 One Solution for Complete Mac Disk Access on Windows – Including Native Encrypted APFS Support
WOODSTOCK, Ill., April 18, 2026 (GLOBE NEWSWIRE) -- WOODSTOCK, Ill. and LAS…
Arclin Completes Acquisition of the DuPont Aramids Business, Including Iconic Kevlar and Nomex Brands
ALPHARETTA, Ga., April 1, 2026 /PRNewswire/ -- Arclin, a global materials science…
Smith+Nephew to feature leading rotator cuff repair portfolio including new Tendon Seam Repair System and REGENETEN Bioinductive Implant at AAOS 2026
Uniting the most advanced technologies for biomechanical repair and biological augmentation Smith+Nephew…
Zealthy ED Platform in 2026 (Including Hardies Sublingual Formulations): Telehealth ED Treatment Options, Compounded Medication Pricing, and What Consumers Should Verify Before Starting
New York, NY, Feb. 27, 2026 (GLOBE NEWSWIRE) -- This article contains…
Eupraxia Pharmaceuticals Announces Closing of US$63.2 Million Public Offering Including Full Exercise of Underwriter Option
February 20, 2026 15:10 ET | Source: Eupraxia Pharmaceuticals Inc. VICTORIA, British…
Total Investment of Approx. USD 8.8 Million in Malaria, Tuberculosis, and NTD R&D Projects with Partners Including Mahidol University, Barcelona Institute for Global Health, and Eisai
TOKYO, Feb. 3, 2026 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund…
